Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce R Schackman

Showing results (191-200 of 222) with videos related to

Pageof 23
Sort By:
JAMA Network Open|September 13, 2023
Economic Evaluation of Extended-Release Buprenorphine for Persons With Opioid Use DisorderJuliet M Flam-Ross, Elizabeth Marsh, Michelle Weitz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2020
The Potential Epidemiological Impact of Coronavirus Disease 2019 (COVID-19) on the Human Immunodeficiency Virus (HIV) Epidemic and the Cost-effectiveness of Linked, Opt-out HIV Testing: A Modeling Study in 6 US CitiesXiao Zang, Emanuel Krebs, Siyuan Chen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 15, 2019
Ending the Epidemic in America Will Not Happen if the Status Quo Continues: Modeled Projections for Human Immunodeficiency Virus Incidence in 6 US CitiesBohdan Nosyk, Xiao Zang, Emanuel Krebs, et al.
Contemporary Clinical Trials|February 26, 2023
Keep It Up! 3.0: Study protocol for a type III hybrid implementation-effectiveness cluster-randomized trialBrian Mustanski, Rana Saber, Justin Patrick Jones, et al.
Substance Use & Misuse|January 15, 2025
"New Normal:" Opportunities and Challenges Faced by Syringe Service Programs Following the Effects of the COVID-19 PandemicElizabeth J Austin, Elsa S Briggs, Maria A Corcorran, et al.
AIDS (London, England)|December 4, 2019
The impact of localized implementation: determining the cost-effectiveness of HIV prevention and care interventions across six United States citiesEmanuel Krebs, Xiao Zang, Benjamin Enns, et al.
JAMA Network Open|June 27, 2025
Health and Economic Outcomes of Addressing Encampments of Individuals Using OpioidsHana Zwick, Ryan O'Dea, Joshua A Barocas, et al.
The Journal of Infectious Diseases|September 3, 2020
Ending the HIV Epidemic Among Persons Who Inject Drugs: A Cost-Effectiveness Analysis in Six US CitiesEmanuel Krebs, Xiao Zang, Benjamin Enns, et al.
JAMA Network Open|February 15, 2021
Projected Estimates of Opioid Mortality After Community-Level InterventionsBenjamin P Linas, Alexandra Savinkina, R W M A Madushani, et al.
The Lancet. HIV|March 9, 2020
Ending the HIV epidemic in the USA: an economic modelling study in six citiesBohdan Nosyk, Xiao Zang, Emanuel Krebs, et al.
Pageof 23

Showing results (191-200 of 222) with videos related to

Sort By:
Pageof 23
JAMA Network Open|September 13, 2023
Economic Evaluation of Extended-Release Buprenorphine for Persons With Opioid Use DisorderJuliet M Flam-Ross, Elizabeth Marsh, Michelle Weitz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2020
The Potential Epidemiological Impact of Coronavirus Disease 2019 (COVID-19) on the Human Immunodeficiency Virus (HIV) Epidemic and the Cost-effectiveness of Linked, Opt-out HIV Testing: A Modeling Study in 6 US CitiesXiao Zang, Emanuel Krebs, Siyuan Chen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 15, 2019
Ending the Epidemic in America Will Not Happen if the Status Quo Continues: Modeled Projections for Human Immunodeficiency Virus Incidence in 6 US CitiesBohdan Nosyk, Xiao Zang, Emanuel Krebs, et al.
Contemporary Clinical Trials|February 26, 2023
Keep It Up! 3.0: Study protocol for a type III hybrid implementation-effectiveness cluster-randomized trialBrian Mustanski, Rana Saber, Justin Patrick Jones, et al.
Substance Use & Misuse|January 15, 2025
"New Normal:" Opportunities and Challenges Faced by Syringe Service Programs Following the Effects of the COVID-19 PandemicElizabeth J Austin, Elsa S Briggs, Maria A Corcorran, et al.
AIDS (London, England)|December 4, 2019
The impact of localized implementation: determining the cost-effectiveness of HIV prevention and care interventions across six United States citiesEmanuel Krebs, Xiao Zang, Benjamin Enns, et al.
JAMA Network Open|June 27, 2025
Health and Economic Outcomes of Addressing Encampments of Individuals Using OpioidsHana Zwick, Ryan O'Dea, Joshua A Barocas, et al.
The Journal of Infectious Diseases|September 3, 2020
Ending the HIV Epidemic Among Persons Who Inject Drugs: A Cost-Effectiveness Analysis in Six US CitiesEmanuel Krebs, Xiao Zang, Benjamin Enns, et al.
JAMA Network Open|February 15, 2021
Projected Estimates of Opioid Mortality After Community-Level InterventionsBenjamin P Linas, Alexandra Savinkina, R W M A Madushani, et al.
The Lancet. HIV|March 9, 2020
Ending the HIV epidemic in the USA: an economic modelling study in six citiesBohdan Nosyk, Xiao Zang, Emanuel Krebs, et al.
Pageof 23